Federal contract award
72061723F00003
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE AND DELIVER A RANGE OF HIV COMMODITIES NAMELY ANTIRETROVIRAL (ARV) CO-TRIMOXAZOLE HIV/SYPHILIS DUO, 25 TESTS (E.G. SD BIOLINE) HIV RAPID RECENCY ASSAY, BULK FORMAT, 100 TESTS/KIT (E.G., ASANTE) AND CRAG
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Agency for International Development |
| Office | USAID/UGANDA |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | R408 — Program Management/Support Services |
| Parent award / vehicle | 72061721D00002 |
| Set-aside | Not reported |
| Pricing type | COST PLUS AWARD FEE |
| Obligations | $57.9M |
| Current contract value | $115.5M |
| Potential contract value / ceiling | $115.5M |
| Start date | May 15, 2023 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Jun 24, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 24, 2026 | P00007 | $2.7M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) PROVIDE 2,661,908 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY |
| May 12, 2026 | P00006 | $1.5M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) PROVIDE 1,540,962.00 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY AND 2) EXTEND THE PERIOD OF PERFORMANCE TO 09/30/2026 |
| Feb 20, 2026 | P00005 | $3.0M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) PROVIDE $3,000,000 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY |
| Sep 26, 2024 | P00004 | $9.6M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) PROVIDE $9,571,849.00 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY THEREBY INCREASING THE TOTAL OBLIGATED AMOUNT TO DATE FROM $41,082,671.01 TO $50,654,520.01 2) UPDATE THE PART I |
| Mar 19, 2024 | P00003 | $3.2M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) PROVIDE $3,183,114.00 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY THEREBY INCREASING THE TOTAL OBLIGATED AMOUNT TO DATE FROM $37,899,557.0 TO $41,082,671.0. 2) UPDATE THE PART I |
| Dec 5, 2023 | P00002 | $10.5M | JMS MEGARFTOP: THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND THE ACTIVITY WITH $ 10,479, 821 THEREBY INCREASING THE TOTAL OBLIGATED AMOUNT FROM $ 27,419,736.01 TO $ 37,899,557.01 |
| Nov 22, 2023 | P00001 | $6.9M | THE PURPOSE OF THIS MODIFICATION IS TO: 1) DECREASE THE TOTAL ESTIMATED COST (TEC) BY $2,600,000.00 FROM $118,067,242.00 TO $115,467,242.00. 2) PROVIDE $6,905,924.00 IN INCREMENTAL FUNDS FOR THE CONTINUED SUPPORT OF THE SUBJECT ACTIVITY THEREBY INC |
| May 12, 2023 | 0 | $20.5M | THE PURPOSE OF THIS TASK ORDER IS TO PROCURE AND DELIVER A RANGE OF HIV COMMODITIES NAMELY ANTIRETROVIRAL (ARV) CO-TRIMOXAZOLE HIV/SYPHILIS DUO, 25 TESTS (E.G. SD BIOLINE) HIV RAPID RECENCY ASSAY, BULK FORMAT, 100 TESTS/KIT (E.G., ASANTE) AND CRAG |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.